Globus Medical GMED Reportable Segment — Business Combination, Acquisition-Related Cost, Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's reportable segment — business combination, acquisition-related cost, expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's reportable segment — business combination, acquisition-related cost, expense?
- Globus Medical (GMED) reported reportable segment — business combination, acquisition-related cost, expense of $6.38M in Q1 2026.
- How has Globus Medical's reportable segment — business combination, acquisition-related cost, expense changed year-over-year?
- Globus Medical's reportable segment — business combination, acquisition-related cost, expense increased by 503.3% year-over-year, from $1.06M to $6.38M.
- What does reportable segment — business combination, acquisition-related cost, expense mean?
- Costs incurred to acquire other companies, such as advisory and legal fees.
- How do you interpret reportable segment — business combination, acquisition-related cost, expense?
- High values indicate an active M&A strategy, which may lead to future revenue growth but also integration risks.
- How does reportable segment — business combination, acquisition-related cost, expense compare across companies?
- Standard M&A transaction cost metric for acquisitive companies.